Kolumne, ORE

Original-Research: MAX Automation SE - von NuWays AG Einstufung von NuWays AG zu MAX Automation SE Unternehmen: MAX Automation SE ISIN: DE000A2DA588 Anlass der Studie: Update Empfehlung: BUY seit: 18.01.2024 Kursziel: 8.20 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Konstantin Völk MAX lays the foundation for outperformance in 2024 Topic: MAX Automation has another promising year in front of it.

18.01.2024 - 09:01:31

Original-Research: MAX Automation SE (von NuWays AG): BUY


Original-Research: MAX Automation SE - von NuWays AG

Einstufung von NuWays AG zu MAX Automation SE

Unternehmen: MAX Automation SE
ISIN: DE000A2DA588

Anlass der Studie: Update
Empfehlung: BUY
seit: 18.01.2024
Kursziel: 8.20
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Konstantin Völk

MAX lays the foundation for outperformance in 2024
 
Topic: MAX Automation has another promising year in front of it. We expect
the company to grow its topline by 7% in 2024e while sustaining last year's
profitability (eNuW).
 
Topline growth ahead: With several structural trends kicking in, MAX should
be able to grow its revenue in the current fiscal year at a
mid-single-digit growth rate. Around 35% of the growth is expected to come
alone from MAX's crown jewel bdtronic (eNuW). With c. 80% of bdtronic's
revenue coming from dispensing solutions mainly in the automotive sector,
bdtronic largely profits from an increasing number of electric components
inside and outside the vehicles. Different dispensing applications are used
to protect electric control units from overheating, vibration during
driving and environmental influences such as salt or dirt. MAX largest
holding, Vecoplan, is expected to grow by 6% in 2024e (eNuW), outpacing the
slow growing recycling market, due to its strong competitive quality.
Vecoplan is an expert in producing machines and plants for shredding,
conveying, and processing of primary and secondary raw materials, such as
wood or plastic.
 
Consistent profitability: We expect MAX to deliver an EBITDA margin of 9.8%
in 2024e, which is roughly in line with 2023e (eNuW). Going forward,
margins should further improve to > 10% by 2025e due to economies of scale
but more importantly due to an improving product mix from bdtronic. Despite
labour cost pressure, the company has not only strong growth potential but
can also improve margins in a tough market due to its technological
leadership.
 
In addition to the improving operating performance, a successful divestment
of the subsidiary MA micro (company news 08.09.2023) should be a notable
share price catalyst, revealing that the value of the "parts" clearly
exceeds the current Enterprise Value of the MAX Automation group, in our
view. A strategic buyer should be willing to pay at least 10x EBITDA for
this highly profitable and return-rich specialty business, implying a
purchase price of above EUR 100m (eNuW).
 
Importantly, even after a divestment, MAX would own hidden Mittelstand
champions such as bdtronic and Vecoplan, amongst other, whose combined
value alone would well exceed the remaining (theoretical) EUR 200m EV of the
group ex MA micro (eNuW), underpinning the undervaluation of the stock.
Hence, we reiterate our BUY rating with an unchanged EUR 8.20 PT based on
DCF.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28703.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...